NEOTRICIN Trademark

Trademark Overview


On Friday, August 19, 1988, a trademark application was filed for NEOTRICIN with the United States Patent and Trademark Office. The USPTO has given the NEOTRICIN trademark a serial number of 73747271. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, June 11, 1990. This trademark is owned by BAUSCH & LOMB PHARMACEUTICALS, INC.. The NEOTRICIN trademark is filed in the Pharmaceutical Products category with the following description:

OPHTHALMIC PHARMACEUTICALS

General Information


Serial Number73747271
Word MarkNEOTRICIN
Filing DateFriday, August 19, 1988
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, June 11, 1990
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesOPHTHALMIC PHARMACEUTICALS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code8 - Abandoned
Class Status DateWednesday, August 4, 1999
Primary Code005
First Use Anywhere DateWednesday, April 20, 1988
First Use In Commerce DateWednesday, April 20, 1988

Trademark Owner History


Party NameBAUSCH & LOMB PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCLEARWATER, FL 34622

Trademark Events


Event DateEvent Description
Monday, June 11, 1990ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, May 8, 1990ASSIGNED TO EXAMINER
Friday, August 18, 1989FINAL REFUSAL MAILED
Friday, July 7, 1989ASSIGNED TO EXAMINER
Friday, November 4, 1988NON-FINAL ACTION MAILED
Tuesday, October 18, 1988ASSIGNED TO EXAMINER